Tristel plc (AIM: TSTL)

Market Cap	208.47M
Revenue (ttm)	41.93M
Net Income (ttm)	6.49M
Shares Out	47.65M
EPS (ttm)	0.14
PE Ratio	32.31
Forward PE	27.68
Dividend	0.14 (3.09%)
Ex-Dividend Date	Nov 28, 2024

Volume	8,881
Open	438.75
Previous Close	440.00
Day's Range	436.83 - 445.00
52-Week Range	346.00 - 510.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 250
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.